This implies MTH1 genetic knockdowns and small molecule inhibition leads to tumor specific DNA damage and senescence both at the in vitro and in vivo levels, while showing minimal outcomes on the normal cells having lower ROS levels. Here, NUDT1 is linked to neoplasm.